193 related articles for article (PubMed ID: 9673257)
1. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae.
Nayak AR; Tinge SA; Tart RC; McDaniel LS; Briles DE; Curtiss R
Infect Immun; 1998 Aug; 66(8):3744-51. PubMed ID: 9673257
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.
Kang HY; Srinivasan J; Curtiss R
Infect Immun; 2002 Apr; 70(4):1739-49. PubMed ID: 11895935
[TBL] [Abstract][Full Text] [Related]
3. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
Xin W; Li Y; Mo H; Roland KL; Curtiss R
Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204
[TBL] [Abstract][Full Text] [Related]
4. The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine.
Xin W; Wanda SY; Zhang X; Santander J; Scarpellini G; Ellis K; Alamuri P; Curtiss R
Infect Immun; 2012 Oct; 80(10):3621-33. PubMed ID: 22868499
[TBL] [Abstract][Full Text] [Related]
5. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
6. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.
Li Y; Wang S; Xin W; Scarpellini G; Shi Z; Gunn B; Roland KL; Curtiss R
Infect Immun; 2008 Nov; 76(11):5238-46. PubMed ID: 18765737
[TBL] [Abstract][Full Text] [Related]
7. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
[TBL] [Abstract][Full Text] [Related]
8. Effect of deletion of gene cluster involved in synthesis of Enterobacterial common antigen on virulence and immunogenicity of live attenuated Salmonella vaccine when delivering heterologous Streptococcus pneumoniae antigen PspA.
Liu Q; Shen X; Bian X; Kong Q
BMC Microbiol; 2020 Jun; 20(1):150. PubMed ID: 32513100
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
[TBL] [Abstract][Full Text] [Related]
10. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.
Redman TK; Harmon CC; Michalek SM
Infect Immun; 1994 Aug; 62(8):3162-71. PubMed ID: 8039885
[TBL] [Abstract][Full Text] [Related]
11. MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.
Park SM; Ko HJ; Shim DH; Yang JY; Park YH; Curtiss R; Kweon MN
J Immunol; 2008 Nov; 181(9):6447-55. PubMed ID: 18941235
[TBL] [Abstract][Full Text] [Related]
12. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.
Miyaji EN; Vadesilho CF; Oliveira ML; Zelanis A; Briles DE; Ho PL
Clin Vaccine Immunol; 2015 Feb; 22(2):213-20. PubMed ID: 25520146
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.
Shi H; Wang S; Curtiss R
Clin Vaccine Immunol; 2013 Jun; 20(6):931-44. PubMed ID: 23616408
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
Miyaji EN; Dias WO; Tanizaki MM; Leite LC
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):53-7. PubMed ID: 12770760
[TBL] [Abstract][Full Text] [Related]
17. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
Kong Q; Liu Q; Roland KL; Curtiss R
Infect Immun; 2009 Dec; 77(12):5572-82. PubMed ID: 19805538
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.
Li Y; Wang S; Scarpellini G; Gunn B; Xin W; Wanda SY; Roland KL; Curtiss R
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):593-8. PubMed ID: 19114649
[TBL] [Abstract][Full Text] [Related]
20. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.
Tart RC; McDaniel LS; Ralph BA; Briles DE
J Infect Dis; 1996 Feb; 173(2):380-6. PubMed ID: 8568299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
